Science
- Illumina launches multiple-gene test to spot rare treatable cancers, article with galleryHealthcare & Pharmaceuticals ·
March 15, 2022 · 4:51 PM UTC Genome sequencing group Illumina on Tuesday launched a cancer test in Europe that checks for a wide range of tumour genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.